Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.
about
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 updateRegulators of autophagosome formation in Drosophila musclesRole of autophagy in glycogen breakdown and its relevance to chloroquine myopathyEmerging therapies for systemic lupus erythematosus--focus on targeting interferon-alphaPUMA: a puzzle piece in chloroquine's antimelanoma activity.A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.Cardiovascular involvement in autoimmune diseases.Regulation of autophagy and chloroquine sensitivity by oncogenic RAS in vitro is context-dependent.Lupus: an overview of the disease and management options.Macroautophagy is deregulated in murine and human lupus T lymphocytesDNA-Containing Immunocomplexes Promote Inflammasome Assembly and Release of Pyrogenic Cytokines by CD14+ CD16+ CD64high CD32low Inflammatory Monocytes from Malaria Patients.B-cell selection and the development of autoantibodies.Hydroxychloroquine is ineffective in treatment of alopecia totalis and extensive alopecia areata: A case series of 8 patientsHydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patientsWhole blood expression profiling from the TREAT trial: insights for the pathogenesis of polyarticular juvenile idiopathic arthritisCardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.Can rheumatoid arthritis be prevented?Psychomotor Agitation Following Treatment with Hydroxychloroquine.Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects.Current immunotherapy in rheumatoid arthritis.Neurology of rheumatologic disorders.Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.Respiratory syncytial virus induces indoleamine 2,3-dioxygenase activity: a potential novel role in the development of allergic disease.Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.Cell wall perturbation sensitizes fungi to the antimalarial drug chloroquine.Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement.The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis.Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.
P2860
Q26859134-73099945-E415-4703-A076-D6EAA9C34B20Q27311465-64C3D85B-22B1-46D6-966C-3A7C327CEBA9Q27316640-9D4E8F71-B663-4AE3-BEC9-CF929195BB9DQ28265144-0FE1F805-7084-4DCC-A974-220A1F6BEB38Q33356363-C64535B0-242B-44C2-AF7C-737B2962D3E4Q33416266-5383A0D9-9831-4227-A004-771EADC159E8Q34081242-B1B09D02-3266-497E-987B-6966E27AD4FCQ34344714-C0256686-95A7-4ECE-92AF-BE163FE5EA44Q34638296-13029376-AA30-4602-AC91-43ACDEBFF2A8Q36194783-1E8BA31F-E951-4E24-BA58-6A23A9D2438AQ36318958-559F9775-A9F3-4BF2-8C15-64BF392D4C71Q36504635-A65AED36-4BFC-4976-A4AC-A0FABBB57DAAQ36735689-35AEB655-457E-4C97-915F-AACC33B10916Q36906782-8876DFDE-1BEC-4A7D-AE30-8E614AB6C501Q37073220-747A9FCF-358C-4482-9ED6-F50F7F24039FQ37330468-CD6A40E9-3EDF-4CB2-81AB-ED3ECBB10E9DQ37589108-AE354B58-0EF7-4634-AF89-5A2A6F3D3B77Q37679958-635B3E18-DB05-4C44-A11D-CC8BBE6874D7Q38029146-591801EB-A3D6-4FEC-8666-1492568A26D6Q38133655-9E5E5194-9B9C-46DD-B9DB-5E72982E2D0DQ38215698-51AFE935-506E-4252-804D-EEA3982026EDQ38561490-7EB5CC9B-0EC6-447A-8B55-90D0FCBD92FAQ38915839-5D8265AF-EBA8-460A-AD1B-6E3A7CCB5498Q41921823-A14E7678-4A74-4AE3-8E3C-3F2685833E6DQ41925517-AB9D6E21-AE30-4D7C-824B-2F811F648002Q41926787-99B8BF52-BC18-4E2B-80CE-906D5E4D454DQ41928709-D5AE494C-9899-4999-BE0D-23980C527C6DQ54207858-CF2553D1-CBD3-40EF-8B2F-62CCC3A06B10Q55025616-FEA9BA2C-19B0-431A-B658-39FFBC46FF67
P2860
Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Re-evaluation of antimalarials ...... into new mechanisms of action.
@en
Re-evaluation of antimalarials ...... into new mechanisms of action.
@nl
type
label
Re-evaluation of antimalarials ...... into new mechanisms of action.
@en
Re-evaluation of antimalarials ...... into new mechanisms of action.
@nl
prefLabel
Re-evaluation of antimalarials ...... into new mechanisms of action.
@en
Re-evaluation of antimalarials ...... into new mechanisms of action.
@nl
P1476
Re-evaluation of antimalarials ...... into new mechanisms of action.
@en
P2093
Anthony S Russell
Steven J Katz
P304
P356
10.1097/BOR.0B013E32834456BF
P577
2011-05-01T00:00:00Z